SCHEDULE 13D

Company

Travere Therapeutics, Inc.

Filed

January 2, 2014

Accession Number

0001376474-14-000001

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →